- Home
- SABS vs WETH Comparison
SABS vs WETH Comparison
Compare SABS & WETH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SABS
- WETH
- Stock Information
- Founded
- SABS 2014
- WETH 1992
- Country
- SABS United States
- WETH China
- Employees
- SABS N/A
- WETH N/A
- Industry
- SABS Biotechnology: Pharmaceutical Preparations
- WETH
- Sector
- SABS Health Care
- WETH
- Exchange
- SABS Nasdaq
- WETH Nasdaq
- Market Cap
- SABS 31.2M
- WETH 26.1M
- IPO Year
- SABS N/A
- WETH N/A
- Fundamental
- Price
- SABS $4.09
- WETH $2.06
- Analyst Decision
- SABS Strong Buy
- WETH
- Analyst Count
- SABS 3
- WETH 0
- Target Price
- SABS $9.00
- WETH N/A
- AVG Volume (30 Days)
- SABS 203.1K
- WETH 306.3K
- Earning Date
- SABS 11-13-2025
- WETH 11-12-2025
- Dividend Yield
- SABS N/A
- WETH N/A
- EPS Growth
- SABS N/A
- WETH 81.55
- EPS
- SABS N/A
- WETH 0.62
- Revenue
- SABS $114,698.00
- WETH $43,519,385.00
- Revenue This Year
- SABS N/A
- WETH N/A
- Revenue Next Year
- SABS N/A
- WETH N/A
- P/E Ratio
- SABS N/A
- WETH $3.22
- Revenue Growth
- SABS N/A
- WETH 6.08
- 52 Week Low
- SABS $1.00
- WETH $0.76
- 52 Week High
- SABS $6.60
- WETH $3.68
- Technical
- Relative Strength Index (RSI)
- SABS 71.11
- WETH 46.86
- Support Level
- SABS $3.68
- WETH $1.87
- Resistance Level
- SABS $4.15
- WETH $2.20
- Average True Range (ATR)
- SABS 0.31
- WETH 0.27
- MACD
- SABS 0.04
- WETH -0.09
- Stochastic Oscillator
- SABS 93.18
- WETH 19.32
About SABS SAB Biotherapeutics Inc.
SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.
About WETH Wetouch Technology Inc.
Wetouch Technology Inc is a touch panel supplier focused on R&D, production, and sales of touch screen products. It offers touchscreens for a variety of applications, including GPS/car entertainment panels for the automotive industry, industrial human-machine interface, financial and banking terminals, point of sale, lottery and gaming machines, smart home, robots, and charging stations. The company sells touchscreen products both domestically in China and internationally. The company generates the majority of its revenue from the PRC, followed by the Republic of China and Korea.